MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...
Posters will be available to view during the ATS Conference, Sunday, May 18 - Wednesday, May 21 during the above times for registered users and on the Presentations page of the company website at ...
Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPF Additional presentations include preclinical and ...
- Oral presentation of ASPIRO results to include additional efficacy and safety data on all patients in dose Cohort 1 and the first treated patients in dose Cohort 2 - Additional presentations include ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, today announced the acceptance of two ...
Chemoradiation and Image-Guided Brachytherapy Alone or in Combination With Protease Inhibitor (Nelfinavir Mesylate) in Stage III Cervical Cancer: Results From a Phase III Trial We retrospectively ...
Alexandra (AJ) Gold recently completed her Ph.D. in English at Boston University. She currently teaches as a Preceptor in the Harvard College Writing Program. Follow her on Twitter @agold258 or check ...
Whether you’re presenting in a boardroom or at a conference, a strong presentation can go a long way toward furthering your career. If you project confidence and competence, you’ll be able to engage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results